Company intelligence / Profile preview
Quorum
Sarasota, Florida, USAquoruminnovations.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Quorum Innovations is a clinical-stage biopharmaceutical company focused on the human microbiome and the science of quorum sensing, or bacterial communication. The company develops microbiome-derived therapies that modulate these communication pathways to treat inflammatory, infectious, and metabolic diseases. Their lead candidate, QI-101, is a novel topical therapy currently in Phase 2 clinical trials for the treatment of atopic dermatitis. Beyond its therapeutic pipeline, Quorum Innovations leverages its platform to develop specialty ingredients and consumer healthcare products designed to restore and maintain a healthy microbiome balance.
- Therapeutic areas
- DermatologyMetabolic Disorders
- Modalities
- Microbial therapyLive biotherapeutic product therapySmall molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Quorum.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Quorum.